Boundless Bio Inc (BOLD) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Boundless Bio Inc   (NASDAQ: BOLD)


Boundless Bio Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Boundless Bio Inc's ROI in the second quarter of 2026?
Boundless Bio Inc recorded a cumulative net loss of $-64 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -51.34%.

Within the Healthcare sector 474 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2172 to 3596.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -30.58 % -17.11 % 1.16 % -13.81 % -33.02 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 66 131 145 157 170
Return On Investment (TTM) -51.34 % -37.14 % -35.46 % -34.78 % -35.85 %
BOLD's Overall Ranking # 3596 # 2172 # 2718 # 3290 # 2100
Seq. Investment Change TTM -17.29 % -8.15 % -7.57 % -1.14 % -1.24 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -64 -56 -58 -62 -64

BOLD Company Profile >> Back to BOLD Roi Comparisons >> See Annual BOLD Return On Investment



Return On Investment BOLD's Ranking
Within: No.
Industry # 201
Sector # 475
Overall # 3596

Return On Investment Statistics
High Average Low
-34.78 %
-44.34 %
-64.34 %
(Sep 30 2025)   (Jun 30 2016)







Financial Statements
Boundless Bio Inc's II. Quarter Investments $ 66 Millions BOLD's Balance sheet
Boundless Bio Inc's II. Quarter Income $ -24 Millions Quarterly BOLD's Income Statement
BOLD's Income by Division See BOLD's Income by Division


BOLD Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Investments in Millions 145 198 449 161 129
Y / Y Investment Growth -27.11 % -55.81 % 178.78 % 24.29 % -
Net Income in Millions -58 -65 -129 -90 -60
Y / Y Net Income Growth - - - - -
Annual Return On Investment -40.27 % -32.97 % -28.71 % -56.07 % -46.08 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BOLD's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BOLD's Competitors
Subscribers only: Roi for Boundless Bio Inc's Suppliers
Subscribers only: Return On Investment for BOLD's Customers

Other Ratios
BOLD's Roa BOLD's Inventory Turnover Ratio BOLD's Growth Rates BOLD's Dividend Statistics
BOLD's Profitability Ratios BOLD's Asset Turnover Ratio BOLD's Dividend Growth
BOLD's Roe BOLD's Valuation Ratios BOLD's Financial Strength Ratios BOLD's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:43:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.